Mindray Medical Announces Pricing of Secondary Offering
01 Febbraio 2007 - 1:00PM
PR Newswire (US)
SHENZHEN, China, Feb. 1 /Xinhua-PRNewswire-FirstCall/ -- Mindray
Medical International Limited (NYSE:MR), a leading developer,
manufacturer and marketer of medical devices in China, today
announced the pricing of its secondary offering of 9,827,220
American Depositary Shares ("ADSs") at US$24.50 per ADS. Each ADS
represents one Class A ordinary share, par value HK$0.001 per
share, of Mindray. All of the ADSs in this offering are being
offered and sold by the selling shareholders of Mindray. Mindray
will not receive any proceeds from the sale of the ADSs in this
offering. Goldman Sachs (Asia) L.L.C., J.P. Morgan Securities Inc.
and UBS AG are acting as the joint bookrunners for this offering.
The underwriters have a 30-day option to purchase up to an
additional 1,474,083 ADSs from the selling shareholders in this
offering. A registration statement relating to these securities has
been filed with, and declared effective by, the Securities and
Exchange Commission. This news release shall not constitute an
offer to sell or a solicitation of an offer to buy any securities,
nor shall there be any sale of these securities in any state or
jurisdiction in which such an offer, solicitation or sale would be
unlawful prior to registration or qualification under the
securities law of any such state or jurisdiction. A copy of the
prospectus relating to the offering may be obtained from Goldman,
Sachs & Co., c/o Prospectus Department, 85 Broad Street, New
York, NY 10004, fax number: 212-902-9316, email: ; J.P. Morgan
Securities Inc., Attention: Prospectus Department, 4 Chase
Metrotech Center, CS Level, Brooklyn, NY 11245, telephone number:
718-242-8002, fax number: 718-242-8003; or UBS Investment Bank,
Prospectus Department, c/o Clint Lauriston, 299 Park Avenue, New
York, NY 10171, telephone number: 212-821-3884, fax number:
212-821-3285, email: . About Mindray Mindray Medical International
Limited is a leading developer, manufacturer and marketer of
medical devices in China with a significant and growing presence
outside of China. Established in 1991, Mindray offers a broad range
of products across three primary business segments: patient
monitoring devices, diagnostic laboratory instruments, and
ultrasound imaging systems. Mindray is headquartered in Shenzhen,
China, and has 29 local sales and services offices in China, as
well as sales and services offices in Boston, Istanbul, London and
Vancouver. For more information, please visit
http://www.mindray.com/ . For more information, please contact: In
China: Investor Relations Mindray Medical International Limited
Tel: +86-755-2658-2518 Email: Philip Lisio Ogilvy Public Relations
Worldwide (Beijing) Tel: +86-10-8520-6688 Email: In U.S.: Thomas
Smith Ogilvy Public Relations Worldwide (New York) Tel:
+1-212-880-5269 DATASOURCE: Mindray Medical International Limited
CONTACT: In China - Investor Relations, Mindray Medical
International Limited , +86-755-2658-2518, or ; or Philip Lisio of
Ogilvy Public Relations Worldwide (Beijing), +86-10-8520-6688, or ;
In U.S. - Thomas Smith of Ogilvy Public Relations Worldwide (New
York), +1-212-880-5269 Web site: http://www.mindray.com/
Copyright
Grafico Azioni Montage Resources (NYSE:MR)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Montage Resources (NYSE:MR)
Storico
Da Lug 2023 a Lug 2024